T. Rowe Price Associates

T. Rowe Price Associates’s Neumora Therapeutics NMRA Stock Holding History

T. Rowe Price Associates’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$33K	Hold
2024 Q4	$346K	Sell
2024 Q3	$8.26M	Sell
2024 Q2	$6.58M	Sell
2024 Q1	$10.4M	Buy